04/12/2024
3:12 PM | G1 Therapeutics (Filer)
| Form PRE 14A | |
04/09/2024
3:29 PM | G1 Therapeutics (Subject)
Velleca Mark A. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/20/2024
3:32 PM | G1 Therapeutics (Issuer)
Umstead John W. V (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
5:35 AM | G1 Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2024
5:14 PM | G1 Therapeutics (Issuer)
Malik Rajesh (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
2:37 PM | Fisher Asset Management, LLC (Filed by)
G1 Therapeutics (Subject)
| Form SCHEDULE 13G | |
01/09/2024
3:19 PM | G1 Therapeutics (Subject)
Velleca Mark A. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
01/08/2024
5:30 AM | G1 Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2024
5:00 AM | G1 Therapeutics (Issuer)
MURDOCK TERRY L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
5:02 AM | Avagliano Mark (Reporting)
G1 Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
5:02 AM | Bailey John E. Jr. (0001806147) (Reporting)
G1 Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
5:03 AM | G1 Therapeutics (Issuer)
Perry Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
5:03 AM | G1 Therapeutics (Issuer)
Malik Rajesh (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
5:03 AM | G1 Therapeutics (Issuer)
Thomas Monica R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
5:04 AM | G1 Therapeutics (Issuer)
Umstead John W. V (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2024
6:44 PM | Bailey John E. Jr. (0001806147) (Reporting)
G1 Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2023
3:45 PM | G1 Therapeutics (Issuer)
Malik Rajesh (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
3:40 PM | G1 Therapeutics (Subject)
Velleca Mark A. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/11/2023
5:43 PM | G1 Therapeutics (Subject)
Malik Rajesh (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/01/2023
3:37 PM | G1 Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/01/2023
5:46 AM | G1 Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/21/2023
3:15 PM | G1 Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2023
6:28 PM | G1 Therapeutics (Subject)
Velleca Mark A. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/02/2023
5:50 AM | G1 Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/07/2023
3:07 PM | Bailey John E. Jr. (0001806147) (Reporting)
G1 Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/07/2023
3:08 PM | G1 Therapeutics (Issuer)
Malik Rajesh (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/07/2023
3:08 PM | G1 Therapeutics (Issuer)
MURDOCK TERRY L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/07/2023
3:08 PM | G1 Therapeutics (Issuer)
Perry Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
3:07 PM | Flowers Cynthia Louise (Reporting)
G1 Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
3:07 PM | G1 Therapeutics (Issuer)
Sharpless Norman (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
3:34 PM | G1 Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/24/2023
3:41 PM | G1 Therapeutics (Issuer)
Thomas Monica R. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/12/2023
3:19 PM | G1 Therapeutics (Issuer)
Perry Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/12/2023
3:19 PM | G1 Therapeutics (Issuer)
Umstead John V. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/12/2023
3:19 PM | G1 Therapeutics (Issuer)
Malik Rajesh (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/12/2023
3:20 PM | Avagliano Mark (Reporting)
G1 Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/12/2023
3:20 PM | G1 Therapeutics (Issuer)
MURDOCK TERRY L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/12/2023
3:16 PM | Bailey John E. Jr. (0001806147) (Reporting)
G1 Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2023
5:46 AM | G1 Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
